1,2,5,6-Tetra-O-((1-(beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl)-1,2,3-triazol-4-yl)methyl)-D-mannitol

ID: ALA5183803

Chembl Id: CHEMBL5183803

PubChem CID: 168281310

Max Phase: Preclinical

Molecular Formula: C66H106N12O46

Molecular Weight: 1803.61

Associated Items:

Names and Identifiers

Canonical SMILES:  OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](n3cc(COC[C@@H](OCc4cn([C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)nn4)[C@@H](O)[C@H](O)[C@@H](COCc4cn([C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)nn4)OCc4cn([C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)nn4)nn3)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C66H106N12O46/c79-5-23-33(87)39(93)51(105)63(117-23)121-55-27(9-83)113-59(47(101)43(55)97)75-1-19(67-71-75)13-109-17-31(111-15-21-3-77(73-69-21)61-49(103)45(99)57(29(11-85)115-61)123-65-53(107)41(95)35(89)25(7-81)119-65)37(91)38(92)32(112-16-22-4-78(74-70-22)62-50(104)46(100)58(30(12-86)116-62)124-66-54(108)42(96)36(90)26(8-82)120-66)18-110-14-20-2-76(72-68-20)60-48(102)44(98)56(28(10-84)114-60)122-64-52(106)40(94)34(88)24(6-80)118-64/h1-4,23-66,79-108H,5-18H2/t23-,24-,25-,26-,27-,28-,29-,30-,31-,32-,33+,34+,35+,36+,37-,38-,39+,40+,41+,42+,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63+,64+,65+,66+/m1/s1

Standard InChI Key:  SBSXGTAKKSWFMS-NMHHKOEOSA-N

Alternative Forms

  1. Parent:

    ALA5183803

    ---

Associated Targets(non-human)

Lgals3 Galectin-3 (98 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Lgals1 Galectin-1 (6 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1803.61Molecular Weight (Monoisotopic): 1802.6324AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Manning JC, Baldoneschi V, Romero-Hernández LL, Pichler KM, GarcÍa Caballero G, André S, Kutzner TJ, Ludwig AK, Zullo V, Richichi B, Windhager R, Kaltner H, Toegel S, Gabius HJ, Murphy PV, Nativi C..  (2022)  Targeting osteoarthritis-associated galectins and an induced effector class by a ditopic bifunctional reagent: Impact of its glycan part on binding measured in the tissue context.,  75  [PMID:36327696] [10.1016/j.bmc.2022.117068]

Source